NumerixS Investment Technologies’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
Other funds holding MYGN
CCM
GCM
DGI
NumerixS Investment Technologies's MYGN Position: Q3 2020 in Review
NumerixS Investment Technologies sold out of Myriad Genetics (MYGN) in Q3 2020, closing a stake of 12,874 shares — an estimated $146K sold.
NumerixS Investment Technologies first reported a position in MYGN in Q3 2015 and held it in 15 quarters. The position peaked at $1.33M in Q2 2016. 192 funds tracked by Wall St. Rank hold MYGN as of Q3 2020.
- NumerixS Investment Technologies reported no remaining Myriad Genetics position as of Q3 2020 after selling out during the quarter.
- NumerixS Investment Technologies sold 12,874 Myriad Genetics shares in Q3 2020, an estimated $146K.
- NumerixS Investment Technologies first reported a position in Myriad Genetics in Q3 2015 and held it in 15 quarters.
- NumerixS Investment Technologies's Myriad Genetics position peaked at $1.33M in Q2 2016.
- 192 funds tracked by Wall St. Rank held Myriad Genetics as of Q3 2020.
Based on NumerixS Investment Technologies's 13F filing for Q3 2020.